Cargando…

Recent Developments in Nanoparticle-Based siRNA Delivery for Cancer Therapy

RNA interference (RNAi) is a gene regulation mechanism initiated by RNA molecules that enables sequence-specific gene silencing by promoting degradation of specific mRNAs. Molecular therapy using small interfering RNA (siRNA) has shown great therapeutic potential for diseases caused by abnormal gene...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Jong-Min, Yoon, Tae-Jong, Cho, Young-Seok
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703404/ https://www.ncbi.nlm.nih.gov/pubmed/23844368 http://dx.doi.org/10.1155/2013/782041

Ejemplares similares

Recent advances in siRNA delivery mediated by lipid-based nanoparticles
por: Yonezawa, Sei, et al.
Publicado: (2020)

Development of Lipidoid Nanoparticles for siRNA Delivery to Neural Cells
por: Khare, Purva, et al.
Publicado: (2021)

Advances in Lipid Nanoparticles for siRNA Delivery
por: Tam, Yuen Yi C., et al.
Publicado: (2013)

BSA Nanoparticles for siRNA Delivery: Coating Effects on Nanoparticle Properties, Plasma Protein Adsorption, and In Vitro siRNA Delivery
por: Yogasundaram, Haran, et al.
Publicado: (2012)

siRNA Delivery Strategies: A Comprehensive Review of Recent Developments
por: Tatiparti, Katyayani, et al.
Publicado: (2017)

Albumin pre-coating enhances intracellular siRNA delivery of multifunctional amphiphile/siRNA nanoparticles
por: Kummitha, China M, et al.
Publicado: (2012)

RNA nanoparticle as a vector for targeted siRNA delivery into glioblastoma mouse model
por: Lee, Tae Jin, et al.
Publicado: (2015)

Intracellular Delivery of siRNA by Polycationic Superparamagnetic Nanoparticles
por: Castillo, Betzaida, et al.
Publicado: (2012)

Ultrasound-Guided Delivery of siRNA and a Chemotherapeutic Drug by Using Microbubble Complexes: In Vitro and In Vivo Evaluations in a Prostate Cancer Model
por: Bae, Yun Jung, et al.
Publicado: (2016)

Self-Assembling β-Glucan Nanomedicine for the Delivery of siRNA
por: Lee, Kyungwoo, et al.
Publicado: (2020)

Lipid and Polymer-Based Nanoparticle siRNA Delivery Systems for Cancer Therapy
por: Mainini, Francesco, et al.
Publicado: (2020)

Dendrimers for siRNA Delivery
por: Biswas, Swati, et al.
Publicado: (2013)

Targeted Delivery of siRNA
por: Oliveira, Sabrina, et al.
Publicado: (2006)

Development and characterization of chitosan-PEG-TAT nanoparticles for the intracellular delivery of siRNA
por: Malhotra, Meenakshi, et al.
Publicado: (2013)

Calcium phosphate nanoparticles-based systems for siRNA delivery
por: Xu, Xiaochun, et al.
Publicado: (2016)

Hydrocarbon-Stapled Peptide Based-Nanoparticles for siRNA Delivery
por: Simon, Matthieu, et al.
Publicado: (2020)

Enzyme-triggered PEGylated siRNA-nanoparticles for controlled release of siRNA
por: Yingyuad, Peerada, et al.
Publicado: (2014)

Synthesis of Polymer-Lipid Nanoparticles by Microfluidic Focusing for siRNA Delivery
por: Li, Yujing, et al.
Publicado: (2016)

Design of a Multicomponent Peptide-Woven Nanocomplex for Delivery of siRNA
por: Jun, Eunsung, et al.
Publicado: (2015)

Photocrosslinked Bioreducible Polymeric Nanoparticles for Enhanced Systemic siRNA Delivery as Cancer Therapy
por: Karlsson, Johan, et al.
Publicado: (2021)

Development of Chitosan Nanoparticles as a Stable Drug Delivery System for Protein/siRNA
por: Katas, Haliza, et al.
Publicado: (2013)

Targeted siRNA Nanoparticles for Mammary Carcinoma Therapy
por: Ben-David-Naim, Meital, et al.
Publicado: (2019)

Aptamer mediated siRNA delivery
por: Chu, Ted C., et al.
Publicado: (2006)

Pulmonary delivery of therapeutic siRNA
por: Lam, Jenny Ka-Wing, et al.
Publicado: (2012)

Intranasal Delivery of Antiviral siRNA
por: Barik, Sailen
Publicado: (2010)

Drug Delivery of siRNA Therapeutics
por: Lamberti, Gaetano, et al.
Publicado: (2020)

Efficiency of siRNA delivery by lipid nanoparticles is limited by endocytic recycling
por: Sahay, Gaurav, et al.
Publicado: (2013)

Degradable Lipid Nanoparticles with Predictable In Vivo siRNA Delivery Activity
por: Whitehead, Kathryn A., et al.
Publicado: (2014)

Polymeric nanoparticles for the delivery of siRNA and the partnership between WSU and UNIT
por: da Rocha, Sandro, et al.
Publicado: (2014)

Oral delivery of siRNA lipid nanoparticles: Fate in the GI tract
por: Ball, Rebecca L., et al.
Publicado: (2018)

Cyclic Peptide-Capped Gold Nanoparticles for Enhanced siRNA Delivery
por: Shirazi, Amir Nasrolahi, et al.
Publicado: (2014)

Polyphosphoester nanoparticles as biodegradable platform for delivery of multiple drugs and siRNA
por: Elzeny, Hadeel, et al.
Publicado: (2017)

Characterization of modified mesoporous silica nanoparticles as vectors for siRNA delivery
por: Slita, Anna, et al.
Publicado: (2018)

Novel Ellipsoid Chitosan-Phthalate Lecithin Nanoparticles for siRNA Delivery
por: Saeed, Ramzi Mukred, et al.
Publicado: (2021)

Microfluidic hydrodynamic focusing synthesis of polymer-lipid nanoparticles for siRNA delivery
por: Huang, Xueqin, et al.
Publicado: (2017)

Targeted delivery of HES5-siRNA with novel polypeptide-modified nanoparticles for hepatocellular carcinoma therapy
por: Xia, Yu, et al.
Publicado: (2018)

Nanoparticle Delivery of Fidgetin siRNA as a Microtubule-based Therapy to Augment Nerve Regeneration
por: Austin, Timothy O., et al.
Publicado: (2017)

Potential of siRNA in COVID-19 therapy: Emphasis on in silico design and nanoparticles based delivery
por: Fopase, Rushikesh, et al.
Publicado: (2023)

Generation of siRNA Nanosheets for Efficient RNA Interference
por: Kim, Hyejin, et al.
Publicado: (2016)

Protection and Systemic Translocation of siRNA Following Oral Administration of Chitosan/siRNA Nanoparticles
por: Ballarín-González, Borja, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_l19bkckilftmbdi528g8uu0iad